Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 640

1.

Effect of a dalteparin prophylaxis protocol using anti-factor Xa concentrations on venous thromboembolism in high-risk trauma patients.

Droege ME, Mueller EW, Besl KM, Lemmink JA, Kramer EA, Athota KP, Droege CA, Ernst NE, Keegan SP, Lutomski DM, Hanseman DJ, Robinson BR.

J Trauma Acute Care Surg. 2014 Feb;76(2):450-6. doi: 10.1097/TA.0000000000000087.

PMID:
24458050
2.

Enoxaparin dose adjustment is associated with low incidence of venous thromboembolic events in acute burn patients.

Lin H, Faraklas I, Saffle J, Cochran A.

J Trauma. 2011 Dec;71(6):1557-61. doi: 10.1097/TA.0b013e31823070f9.

PMID:
22027887
4.

Hypercoagulability and other risk factors in trauma intensive care unit patients with venous thromboembolism.

Van Haren RM, Valle EJ, Thorson CM, Jouria JM, Busko AM, Guarch GA, Namias N, Livingstone AS, Proctor KG.

J Trauma Acute Care Surg. 2014 Feb;76(2):443-9. doi: 10.1097/TA.0b013e3182a9d11d.

PMID:
24398771
5.

Is low-molecular-weight heparin safe for venous thromboembolism prophylaxis in patients with traumatic brain injury? A Western Trauma Association multicenter study.

Kwiatt ME, Patel MS, Ross SE, Lachant MT, MacNew HG, Ochsner MG, Norwood SH, Speier L, Kozar R, Gerber JA, Rowell S, Krishnakumar S, Livingston DH, Manis G, Haan JM.

J Trauma Acute Care Surg. 2012 Sep;73(3):625-8.

PMID:
22929493
6.
7.

Dalteparin versus enoxaparin for venous thromboembolism prophylaxis in acute spinal cord injury and major orthopedic trauma patients: 'DETECT' trial.

Slavik RS, Chan E, Gorman SK, de Lemos J, Chittock D, Simons RK, Wing PC, Ho SG.

J Trauma. 2007 May;62(5):1075-81; discussion 1081.

PMID:
17495705
8.

A retrospective analysis of the effectiveness of low molecular weight heparin for venous thromboembolism prophylaxis in trauma patients.

Gritsiouk Y, Hegsted DA, Schlesinger P, Gardiner SK, Gubler KD.

Am J Surg. 2014 May;207(5):648-51; discussion 651-2. doi: 10.1016/j.amjsurg.2013.12.010.

PMID:
24560359
9.

Implementation of an enoxaparin protocol for venous thromboembolism prophylaxis in obese surgical intensive care unit patients.

Ludwig KP, Simons HJ, Mone M, Barton RG, Kimball EJ.

Ann Pharmacother. 2011 Nov;45(11):1356-62. doi: 10.1345/aph.1Q313.

PMID:
22009998
11.

Multicenter dose-finding and efficacy and safety outcomes in neonates and children treated with dalteparin for acute venous thromboembolism.

O'Brien SH, Kulkarni R, Wallace A, Hamblin F, Burr S, Goldenberg NA.

J Thromb Haemost. 2014 Nov;12(11):1822-5. doi: 10.1111/jth.12716.

12.

Alternative dosing of prophylactic enoxaparin in the trauma patient: is more the answer?

Kopelman TR, O'Neill PJ, Pieri PG, Salomone JP, Hall ST, Quan A, Wells JR, Pressman MS.

Am J Surg. 2013 Dec;206(6):911-5; discussion 915-6. doi: 10.1016/j.amjsurg.2013.10.005.

PMID:
24296098
13.

Early venous thromboembolic event prophylaxis in traumatic brain injury with low-molecular-weight heparin: risks and benefits.

Dudley RR, Aziz I, Bonnici A, Saluja RS, Lamoureux J, Kalmovitch B, Gursahaney A, Razek T, Maleki M, Marcoux J.

J Neurotrauma. 2010 Dec;27(12):2165-72. doi: 10.1089/neu.2010.1366.

PMID:
20939698
14.

Dose adjusting enoxaparin is necessary to achieve adequate venous thromboembolism prophylaxis in trauma patients.

Costantini TW, Min E, Box K, Tran V, Winfield RD, Fortlage D, Doucet J, Bansal V, Coimbra R.

J Trauma Acute Care Surg. 2013 Jan;74(1):128-33; discussion 134-5. doi: 10.1097/TA.0b013e3182788fa7.

15.

Risk stratification and heparin prophylaxis to prevent venous thromboembolism in pregnant women.

Bauersachs RM, Dudenhausen J, Faridi A, Fischer T, Fung S, Geisen U, Harenberg J, Herchenhan E, Keller F, Kemkes-Matthes B, Schinzel H, Spannagl M, Thaler CJ; EThIG Investigators..

Thromb Haemost. 2007 Dec;98(6):1237-45.

PMID:
18064320
16.

Oral direct factor Xa inhibition with edoxaban for thromboprophylaxis after elective total hip replacement. A randomised double-blind dose-response study.

Raskob G, Cohen AT, Eriksson BI, Puskas D, Shi M, Bocanegra T, Weitz JI.

Thromb Haemost. 2010 Sep;104(3):642-9. doi: 10.1160/TH10-02-0142.

PMID:
20589317
17.

Effect of prophylactic dalteparin on anti-factor Xa levels in morbidly obese patients after bariatric surgery.

Simoneau MD, Vachon A, Picard F.

Obes Surg. 2010 Apr;20(4):487-91. doi: 10.1007/s11695-008-9738-x.

PMID:
18931882
18.

Prospective Evaluation of Weight-Based Prophylactic Enoxaparin Dosing in Critically Ill Trauma Patients: Adequacy of AntiXa Levels Is Improved.

Nunez JM, Becher RD, Rebo GJ, Farrah JP, Borgerding EM, Stirparo JJ, Lauer C, Kilgo P, Miller PR.

Am Surg. 2015 Jun;81(6):605-9.

PMID:
26031274
19.

Venous thromboembolism after trauma: a never event?*.

Thorson CM, Ryan ML, Van Haren RM, Curia E, Barrera JM, Guarch GA, Busko AM, Namias N, Livingstone AS, Proctor KG.

Crit Care Med. 2012 Nov;40(11):2967-73. doi: 10.1097/CCM.0b013e31825bcb60.

PMID:
22890248
20.

Heparin versus enoxaparin for prevention of venous thromboembolism after trauma: A randomized noninferiority trial.

Olson EJ, Bandle J, Calvo RY, Shackford SR, Dunne CE, Van Gent JM, Zander AL, Sikand H, Bongiovanni MS, Sise MJ, Sise CB.

J Trauma Acute Care Surg. 2015 Dec;79(6):961-8; discussion 968-9. doi: 10.1097/TA.0000000000000750.

PMID:
26317819

Supplemental Content

Support Center